Swiss - Delayed Quote • CHF
Lonza Group AG (LONN.SW)
As of 10:16 AM GMT+2. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2022) | Next Qtr. (Dec 2022) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 16 | 16 |
| Avg. Estimate | 0 | 0 | 15.19 | 18.03 |
| Low Estimate | 0 | 0 | 14.38 | 17.22 |
| High Estimate | 0 | 0 | 16.7 | 20.04 |
| Year Ago EPS | -- | -- | 12.63 | 15.19 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2022) | Next Qtr. (Dec 2022) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 19 | 19 |
| Avg. Estimate | -- | -- | 6.2B | 6.94B |
| Low Estimate | -- | -- | 6.01B | 6.73B |
| High Estimate | -- | -- | 6.4B | 7.28B |
| Year Ago Sales | -- | -- | 5.41B | 6.2B |
| Sales Growth (year/est) | -- | -- | 14.70% | 11.90% |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2022) | Next Qtr. (Dec 2022) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 15.19 | 18.03 |
| 7 Days Ago | 0 | 0 | 15.19 | 18.03 |
| 30 Days Ago | 0 | 0 | 15.22 | 18.01 |
| 60 Days Ago | 0 | 0 | 15.22 | 17.89 |
| 90 Days Ago | 0 | 0 | 15.43 | 18.1 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2022) | Next Qtr. (Dec 2022) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 1 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| CURRENCY IN USD | LONN.SW | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 6.50% |
| Next Qtr. | -- | -- | -- | 12.00% |
| Current Year | 20.30% | -- | -- | 5.30% |
| Next Year | 18.70% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 19.14% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 2.01% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
No Fair Value available for this ticker
Related Tickers
IQV IQVIA Holdings Inc.
234.88
+0.38%
CRL Charles River Laboratories International, Inc.
229.03
+0.54%
TN8.SG Thermo Fisher Scientific Inc
535.50
-0.17%
ICLR ICON Public Limited Company
308.31
+2.74%
QGEN Qiagen N.V.
41.65
+1.39%
SHL.AX Sonic Healthcare Limited
26.76
+1.59%
TMO Thermo Fisher Scientific Inc.
573.60
+0.33%
WAT Waters Corporation
311.30
+0.96%
IDXX IDEXX Laboratories, Inc.
499.30
+2.06%
DHR Danaher Corporation
246.58
+0.32%